Parnax Lab is currently trading at Rs. 59.95, up by 7.90 points or 15.18% from its previous closing of Rs. 52.05 on the BSE.
The scrip opened at Rs. 54.90 and has touched a high and low of Rs. 60.80 and Rs. 54.55 respectively. So far 46,000 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 78.00 on 24-Apr-2017 and a 52 week low of Rs. 40.20 on 28-Mar-2018.
Last one week high and low of the scrip stood at Rs. 60.80 and Rs. 48.05 respectively. The current market cap of the company is Rs. 50.99 crore.
The promoters holding in the company stood at 62.59%, while Non-Institutions held 37.41% stake in the company.
Parnax Lab’s subsidiary -- Naxpar Pharma has received an export order amounting to 4.44 million euro.
Parnax Lab is also known as Naxpar and its key strength is manufacturing finished formulations for multinationals in India and abroad and in emerging pharmaceutical markets such as Nigeria, Kazakhstan, Kenya, Mauritius etc.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1696.95 |
Dr. Reddys Lab | 1152.40 |
Cipla | 1444.55 |
Lupin | 1956.40 |
Zydus Lifesciences | 877.50 |
View more.. |